情感障碍对梅尼埃病影响的研究进展
Research Progress on the Impact of Affective Disorders on Meniere Disease
胡涛;屈永涛;郭明丽
1:河北北方学院
2:河北省人民医院耳鼻咽喉科
1 Nakayama M,Kabaya K.Obstructive sleep apnea syndrome as a novel cause for Ménière's disease[J].Curr Opin Otolaryngol Head Neck Surg,2013,21(5):503-508.
2 Yokota Y,Kitahara T,Sakagami M,et al.Surgical results and psychological status in patients with intractable Ménière's disease[J].Auris Nasus Larynx,2016,43(3):287-291.
3 Beurel E,Nemeroff CB.Interaction of stress,corticotropin-releasing factor,arginine vasopressin and behaviour[J].Curr Top Behav Neurosci,2014,18:67-80.
4 Chung SD,Hung SH,Lin HC,et al.Association between sudden sensorineural hearing loss and anxiety disorder:a population-based study[J].Eur Arch Otorhinolaryngol,2015,272(10):2673-2678.
5 Kim SY,Lee CH,Min C,et al.Bidirectional analysis of the association between Ménière's disease and depression:two longitudinal follow-up studies using a national sample cohort[J].Clin Otolaryngol,2020,45(5):687-694.
6 Seo YJ,Kim J,Kim SH.The change of hippocampal volume and its relevance with inner ear function in Meniere's disease patients[J].Auris Nasus Larynx,2016,43(6):620-625.
7 Duman RS,Aghajanian GK,Sanacora G,et al.Synaptic plasticity and depression:new insights from stress and rapid-acting antidepressants[J].Nat Med,2016,22(3):238-249.
8 Furukawa M,Kitahara T,Horii A,et al.Psychological condition in patients with intractable Meniere's disease[J].Acta Otolaryngol,2013,133(6):584-589.
9 Roh KJ,Kim MK,Kim JH,et al.Role of emotional distress in prolongation of dizziness:a cross-sectional study[J].J Audiol Otol,2017,22(1):6-12.
10 Coto J,Alvarez CL,Cejas I,et al.Peripheral vestibular system:age-related vestibular loss and associated deficits[J].J Otol,2021,16(4):258-265.
11 李非田,戴春富.外周性眩晕并发焦虑的神经生物学机制[J].中国眼耳鼻喉科杂志,2018,18(2):134-6,41.
12 Boku S,Nakagawa S,Toda H,et al.Neural basis of major depressive disorder:beyond monoamine hypothesis[J].Psychiatry Clin Neurosci,2018,72(1):3-12.
13 Miller AH,Raison CL.The role of inflammation in depression:from evolutionary imperative to modern treatment target[J].Nat Rev Immunol,2016,16(1):22-34.
14 Froehlich MH,Lambert PR.The physiologic role of corticosteroids in menière's disease:an update on glucocorticoid-mediated pathophysiology and corticosteroid inner ear distribution[J].Otol Neurotol,2020,41(2):271-276.
15 Kim SH,Kim BG,Kim JY,et al.Electrogenic transport and K+ ion channel expression by the human endolymphatic sac epithelium[J].Sci Rep,2015,5:18110.
16 Takeda T,Takeda S,Kakigi A.Effects of glucocorticoids on the inner ear[J].Front Surg,2020,7:596383.
17 Cavaillon JM.Exotoxins and endotoxins:inducers of inflammatory cytokines[J].Toxicon,2018,149:45-53.
18 Dowlati Y,Herrmann N,Swardfager W,et al.A meta-analysis of cytokines in major depression[J].Biol Psychiatry,2010,67(5):446-457.
19 Sheng W,Zong Y,Mohammad A,et al.Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology,and upregulation of ERK1/2,iNOS and sPLA2-IIA expression in astrocytes and microglia[J].J Neuroinflammation,2011,8:121.
20 Burokas A,Arboleya S,Moloney RD,et al.Targeting the microbiota-gut-brain axis:prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice[J].Biol Psychiatry,2017,82(7):472-487.
21 Henderson I,Caiazzo E,Mcsharry C,et al.Why do some asthma patients respond poorly to glucocorticoid therapy[J]?Pharmacol Res,2020,160:105189.
22 Frejo L,Requena T,Okawa S,et al.Regulation of Fn14 receptor and NF-κB underlies inflammation in meniere's disease[J].Front Immunol,2017,8:1739.
23 Zhang G,Zheng H,Pyykko I,et al.The TLR-4/NF-κB signaling pathway activation in cochlear inflammation of rats with noise-induced hearing loss[J].Hear Res,2019,379:59-68.
24 Xia L,Liu J,Sun Y,et al.Rosiglitazone improves glucocorticoid resistance in a sudden sensorineural hearing loss by promoting MAP kinase phosphatase-1 expression[J].Mediators Inflamm,2019,2019:7915730.
25 Corbani M,Marir R,Trueab M,et al.Neuroanatomical distribution and function of the vasopressin V(1B) receptor in the rat brain deciphered using specific fluorescent ligands[J].Gen Comp Endocrinol,2018,258:15-32.
26 Chaki S.Vasopressin V1B receptor antagonists as potential antidepressants[J].Int J Neuropsychopharmacol,2021,24(6):450-463.
27 Bao AM,Swaab DF.The human hypothalamus in mood disorders:the HPA axis in the center[J].IBRO Rep,2019,6:45-53.
28 Hernández VS,Hernández OR,Perez De La Mora M,et al.Hypothalamic vasopressinergic projections innervate central amygdala GABAergic neurons:implications for anxiety and stress coping[J].Front Neural Circuits,2016,10:92.
29 Dong SH,Kim SS,Kim SH,et al.Expression of aquaporins in inner ear disease[J].Laryngoscope,2020,130(6):1532-1539.
30 Runggaldier D,Pradas LG,Neckel PH,et al.Claudin expression in the rat endolymphatic duct and sac—first insights into regulation of the paracellular barrier by vasopressin[J].Sci Rep,2017,7:45482.
31 Naganuma H,Kawahara K,Tokumasu K,et al.Effects of arginine vasopressin on auditory brainstem response and cochlear morphology in rats[J].Auris Nasus Larynx,2014,41(3):249-254.
32 Demiselle J,Fage N,Radermacher P,et al.Vasopressin and its analogues in shock states:a review[J].Ann Intensive Care,2020,10(1):9.
33 Zhong SX,Hu GH,Liu ZH.Expression of ENaC,SGK1 and Nedd4 isoforms in the cochlea of guinea pig[J].Folia Histochem Cytobiol,2014,52(2):144-148.
34 Mccann KE,Lustberg DJ,Shaughnessy EK,et al.Novel role for mineralocorticoid receptors in control of a neuronal phenotype[J].Mol Psychiatry,2021,26(1):350-364.
35 Apostolopoulou K,Künzel HE,Gerum S,et al.Gender differences in anxiety and depressive symptoms in patients with primary hyperaldosteronism:a cross-sectional study[J].World J Biol Psychiatry,2014,15(1):26-35.
36 Qin L,Zhang B,Wang Q,et al.Effect of aldosterone on cochlear Af9 expression and hearing in guinea pig[J].Acta Otolaryngol,2017,137(9):903-909.
37 Chen ZW,Tsai CH,Pan CT,et al.Endothelial dysfunction in primary aldosteronism[J].Int J Mol Sci,2019,20(20):5214-5238.
38 Overton M.Meniere's disease:some patients benefit significantly from SSRIs[J].Aust Fam Physician,2003,32(1-2):8.
39 Goto F,Tsutsumi T,Ogawa K.Successful treatment of relapsed Ménière's disease using selective serotonin reuptake inhibitors:a report of three cases[J].Exp Ther Med,2014,7(2):488-490.
40 Zhank K,Li Q,Xu J,et al.Unilateral horizontal semicircular canal occlusion induces serotonin increase in medial vestibular nuclei:a study using microdialysis in vivo coupled with HPLC-ECD[J].Analyst,2015,140(11):3846-3851.
41 Nakashima T,Pyykko I,Arroll MA,et al.Meniere's disease[J].Nat Rev Dis Primers,2016,2:16028.
42 中国医药教育协会眩晕专业委员会.几种国际梅尼埃病诊治指南的比较[J].听力学及言语疾病杂志,2022,30(5):461-464.
43 戴硕,何晓,唐旭霞.梅尼埃病的发病机制及临床诊治研究进展[J].听力学及言语疾病杂志,2022,30(5):476-480.